Re-evolving therapeutics with software
CureApp (cureapp.co.jp) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, SaaS brands, Technology brands, in the 13th percentile of 16260 Healthcare brands.
CureApp is a Japanese healthcare technology company headquartered in Nihonbashi-Kodenmachō that develops 'treatment apps' - evidence-based, prescription software medical devices classified as digital therapeutics. The company aims to address social challenges in healthcare by creating technology-powered treatments for conditions where conventional drugs or hardware devices are insufficient. CureApp positions itself as a pioneer in digital therapeutics, targeting patients, healthcare providers, and occupational health professionals seeking clinically validated, software-based treatment options within the SaaS and healthcare technology space.
| Brand Name | CureApp |
|---|---|
| Domain | cureapp.co.jp |
| Industry | Healthcare, SaaS |
| Headquarters | Nihonbashi-Kodenmachō |
| Main Competitors | Akili Interactive (81/100), Pear Therapeutics, Welldoc (82/100), Omada Health (83/100), Click Therapeutics (78/100) |
Moz Domain Authority 42/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,022,499 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "私たちCureAppは、進化するテクノロジーを活用した新しい治療を生み出すことで医療を取り巻く社会課題を解決し、全ての人が安心して質の高い治療を受けられる理想の医療を実現します。" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is JA-only, limiting citation in English-language AI answers.
Detected tech stack: HubSpot.
Social footprint: verified profiles on X (Twitter), GitHub, Instagram, YouTube; no detected presence on Facebook, LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is CureApp?", Claude could identify the brand as of October 2026. CureApp is a Japanese digital therapeutics company that develops prescription smartphone apps designed to treat conditions like nicotine addiction, hypertension, and NASH (nonalcoholic steatohepatitis) alongside traditional medical care. It gained attention for creating Japan's f Best known for developing Japan's first approved prescription digital therapeutics app for smoking cessation.
When asked "Best brands similar to CureApp?", Claude would recommend CureApp as of October 2026. It's a pioneering and well-documented player in the digital therapeutics space, especially notable in the Japanese healthcare market.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CureApp's main competitors in Healthcare: Akili Interactive (81/100), Welldoc (82/100), Omada Health (83/100), Click Therapeutics (78/100).
Sources: Brand Analyzer scan
CureApp has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 34, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CureApp official site
CureApp is headquartered in Nihonbashi-Kodenmachō. CureApp operates in the Healthcare category.
Sources: Wikidata
CureApp scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CureApp official site
CureApp is a Japanese healthcare technology company that develops digital therapeutics, specifically prescription software medical devices referred to as 'treatment apps.' Headquartered in Nihonbashi-Kodenmachō, the company focuses on creating evidence-based, technology-driven treatments for diseases where conventional drugs or hardware devices are insufficient. It operates in the healthcare, SaaS, and technology categories, positioning itself as a pioneer bridging medical science and software to reinvent clinical treatment delivery.
Sources: CureApp official site
CureApp develops digital therapeutics in the form of prescription software medical devices, called 'treatment apps,' designed to deliver clinically validated treatment for diseases that are not adequately addressed by conventional drugs or hardware devices. The company's goal is to solve social challenges surrounding healthcare by using evolving technology to create new treatment pathways, aiming to ensure that all patients can safely access high-quality care through software-based medical interventions.
Sources: CureApp official site
CureApp can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CureApp official site
CureApp offers 'treatment apps' - prescription software medical devices that function as digital therapeutics. These are evidence-based tools designed to treat diseases and conditions that are not adequately managed by conventional pharmaceutical drugs or hardware medical devices. The company's offerings are aimed at healthcare providers, occupational health professionals, and patients seeking clinically validated, technology-based treatment alternatives within a regulated medical device framework.
Sources: CureApp official site
CureApp is known for pioneering digital therapeutics in Japan through its development of 'treatment apps' - evidence-based, prescription software medical devices intended to treat conditions where traditional drug or hardware-based treatments fall short. The company is recognized for positioning itself at the intersection of medical science and software technology, aiming to reinvent how clinical treatment is delivered to patients, healthcare providers, and occupational health professionals.
Sources: CureApp official site
CureApp's treatment apps are used by patients suffering from conditions that are inadequately addressed by conventional medicine, as well as by healthcare providers and occupational health professionals who prescribe or administer these evidence-based digital treatment solutions. The company's target audience includes those seeking clinically validated, technology-driven alternatives to traditional drug or hardware-based treatments.
Sources: CureApp official site
CureApp scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CureApp has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (23/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,022,499 (Tranco) and a Moz Domain Authority of 42/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CureApp from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CureApp: Cold Spring Harbor Laboratory (66/100), CP Consulting (66/100), DailyRounds (66/100), D.A.W. Systems, Inc. (66/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.